Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Diabetes

SGLT2 inhibitors linked to increased risk of diabetic ketoacidosis

In a study comparing treatments for type 2 diabetes, SGLT2 inhibitors show double the risk of ketoacidosis versus gliptins.

Case reports have indicated that initiation of sodium-glucose cotransporter 2 (SGLT2) inhibitors for type 2 diabetes may cause diabetic ketoacidosis, which led to a warning from the US Food and Drug Administration in May 2015.

In a new study published in The New England Journal of Medicine[1] (online, 8 June 2017), researchers used insurance claims data from the United States to compare 50,220 patients who had just started taking an SGLT2 inhibitor with 90,132 who had just started taking a dipeptidyl peptidase-4 (DPP4) inhibitor.

They found that the risk of diabetic ketoacidosis by day 180 was double in patients who initiated SGLT2 inhibitors compared with those who received DPP4 inhibitors, at a rate of 4.9 versus 2.3 events per 1,000 person-years (hazard ratio 2.1; 95% confidence interval [CI] 1.5 to 2.9).

Diabetic ketoacidosis should be considered both at the time of prescribing and if patients present with potential symptoms during treatment, the authors conclude.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20202979

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmacy Registration Assessment Questions 3

    Pharmacy Registration Assessment Questions 3

    Pharmacy Registration Assessment Questions 3 is the third volume in a series that follows on from the previous, highly popular Pharmacy Registration Assessment Questions 2. It features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own.

    £35.00Buy now
  • FASTtrack: Pharmacology

    FASTtrack: Pharmacology

    FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.

    £25.00Buy now
  • Introduction to Pharmaceutical Calculations

    Introduction to Pharmaceutical Calculations

    Introduction to Pharmaceutical Calculations is an essential study aid for pharmacy students. The book contains worked examples and sample questions and answers.

    £33.00Buy now
  • Lecture Notes in Pharmacy Practice

    Lecture Notes in Pharmacy Practice

    A comprehensive study guide which summarises the basic principles in pharmacy practice. Clear, bulleted information for quick reference.

    £43.00Buy now
  • MCQs in Pharmacy Practice

    MCQs in Pharmacy Practice

    A study aid with 800 MCQs. Assess your knowledge, analytical skills, and ability to apply this knowledge base in clinical practice.

    £25.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.